Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve consider and approve the Audited Financial Statement including Balance Sheet, as at 31st March, 2026, Statement of Profit and Loss, Cash Flow and Notes thereon for the year ended 31st March, 2026.